Drugs and pharmaceuticals: management of intoxication and antidotes.

EXS Pub Date : 2010-01-01 DOI:10.1007/978-3-7643-8338-1_12
Silas W Smith
{"title":"Drugs and pharmaceuticals: management of intoxication and antidotes.","authors":"Silas W Smith","doi":"10.1007/978-3-7643-8338-1_12","DOIUrl":null,"url":null,"abstract":"<p><p>The treatment of patients poisoned with drugs and pharmaceuticals can be quite challenging. Diverse exposure circumstances, varied clinical presentations, unique patient-specific factors, and inconsistent diagnostic and therapeutic infrastructure support, coupled with relatively few definitive antidotes, may complicate evaluation and management. The historical approach to poisoned patients (patient arousal, toxin elimination, and toxin identification) has given way to rigorous attention to the fundamental aspects of basic life support--airway management, oxygenation and ventilation, circulatory competence, thermoregulation, and substrate availability. Selected patients may benefit from methods to alter toxin pharmacokinetics to minimize systemic, target organ, or tissue compartment exposure (either by decreasing absorption or increasing elimination). These may include syrup of ipecac, orogastric lavage, activated single- or multi-dose charcoal, whole bowel irrigation, endoscopy and surgery, urinary alkalinization, saline diuresis, or extracorporeal methods (hemodialysis, charcoal hemoperfusion, continuous venovenous hemofiltration, and exchange transfusion). Pharmaceutical adjuncts and antidotes may be useful in toxicant-induced hyperthermias. In the context of analgesic, anti-inflammatory, anticholinergic, anticonvulsant, antihyperglycemic, antimicrobial, antineoplastic, cardiovascular, opioid, or sedative-hypnotic agents overdose, N-acetylcysteine, physostigmine, L-carnitine, dextrose, octreotide, pyridoxine, dexrazoxane, leucovorin, glucarpidase, atropine, calcium, digoxin-specific antibody fragments, glucagon, high-dose insulin euglycemia therapy, lipid emulsion, magnesium, sodium bicarbonate, naloxone, and flumazenil are specifically reviewed. In summary, patients generally benefit from aggressive support of vital functions, careful history and physical examination, specific laboratory analyses, a thoughtful consideration of the risks and benefits of decontamination and enhanced elimination, and the use of specific antidotes where warranted. Data supporting antidotes effectiveness vary considerably. Clinicians are encouraged to utilize consultation with regional poison centers or those with toxicology training to assist with diagnosis, management, and administration of antidotes, particularly in unfamiliar cases.</p>","PeriodicalId":77125,"journal":{"name":"EXS","volume":"100 ","pages":"397-460"},"PeriodicalIF":0.0000,"publicationDate":"2010-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7123602/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"EXS","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/978-3-7643-8338-1_12","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The treatment of patients poisoned with drugs and pharmaceuticals can be quite challenging. Diverse exposure circumstances, varied clinical presentations, unique patient-specific factors, and inconsistent diagnostic and therapeutic infrastructure support, coupled with relatively few definitive antidotes, may complicate evaluation and management. The historical approach to poisoned patients (patient arousal, toxin elimination, and toxin identification) has given way to rigorous attention to the fundamental aspects of basic life support--airway management, oxygenation and ventilation, circulatory competence, thermoregulation, and substrate availability. Selected patients may benefit from methods to alter toxin pharmacokinetics to minimize systemic, target organ, or tissue compartment exposure (either by decreasing absorption or increasing elimination). These may include syrup of ipecac, orogastric lavage, activated single- or multi-dose charcoal, whole bowel irrigation, endoscopy and surgery, urinary alkalinization, saline diuresis, or extracorporeal methods (hemodialysis, charcoal hemoperfusion, continuous venovenous hemofiltration, and exchange transfusion). Pharmaceutical adjuncts and antidotes may be useful in toxicant-induced hyperthermias. In the context of analgesic, anti-inflammatory, anticholinergic, anticonvulsant, antihyperglycemic, antimicrobial, antineoplastic, cardiovascular, opioid, or sedative-hypnotic agents overdose, N-acetylcysteine, physostigmine, L-carnitine, dextrose, octreotide, pyridoxine, dexrazoxane, leucovorin, glucarpidase, atropine, calcium, digoxin-specific antibody fragments, glucagon, high-dose insulin euglycemia therapy, lipid emulsion, magnesium, sodium bicarbonate, naloxone, and flumazenil are specifically reviewed. In summary, patients generally benefit from aggressive support of vital functions, careful history and physical examination, specific laboratory analyses, a thoughtful consideration of the risks and benefits of decontamination and enhanced elimination, and the use of specific antidotes where warranted. Data supporting antidotes effectiveness vary considerably. Clinicians are encouraged to utilize consultation with regional poison centers or those with toxicology training to assist with diagnosis, management, and administration of antidotes, particularly in unfamiliar cases.

药物和药品:中毒处理和解毒剂。
对药物中毒患者的治疗极具挑战性。不同的接触环境、不同的临床表现、独特的患者特异性因素、不一致的诊断和治疗基础设施支持,再加上相对较少的明确解毒剂,可能会使评估和管理复杂化。以往处理中毒患者的方法(唤醒患者、排除毒素和识别毒素)已让位于对基本生命支持基本方面的严格关注--气道管理、供氧和通气、循环能力、体温调节和底物供应。某些患者可能会受益于改变毒素药代动力学的方法,以最大限度地减少全身、靶器官或组织间的暴露(通过减少吸收或增加排出)。这些方法可能包括异丙嗪糖浆、口胃灌洗、活性单剂量或多剂量木炭、全肠灌洗、内窥镜检查和手术、尿碱化、生理盐水利尿或体外方法(血液透析、木炭血液灌流、连续静脉血液滤过和交换性输血)。药物辅助治疗和解毒剂对毒物诱发的高热可能有用。在镇痛剂、抗炎药、抗胆碱能药、抗惊厥药、降血糖药、抗菌药、抗肿瘤药、心血管药、阿片类药物或镇静催眠药用药过量的情况下,可使用 N-乙酰半胱氨酸、鹅肌肽、L-肉碱、葡萄糖、奥曲肽、吡哆醇、地塞米松、奥曲肽等药物、特别回顾了吡哆醇、右雷佐辛、利血平、葡萄糖苷酶、阿托品、钙、地高辛特异性抗体片段、胰高血糖素、大剂量胰岛素优糖疗法、脂质乳剂、镁、碳酸氢钠、纳洛酮和氟马西尼。总之,积极支持生命机能、仔细询问病史和进行体格检查、进行特定的实验室分析、深思熟虑地考虑净化和加强排毒的风险和益处,以及在必要时使用特定解毒剂,患者一般都能从中获益。支持解毒剂有效性的数据差异很大。我们鼓励临床医生向地区毒物中心或接受过毒理学培训的人员咨询,以协助诊断、管理和使用解毒剂,尤其是在不熟悉的情况下。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
EXS
EXS
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信